Avelumab Survey for Merkel Cell Carcinoma Patients

Avelumab Survey for Merkel Cell Carcinoma Patients

(Note: blog post updated November 14, 2017)

Save Your Skin Foundation, in collaboration with Canadian Cancer Survivor Network, submitted the patient perspective on Avelumab (Bavencio) treatment for Merkel Cell Carcinoma, a rare form of skin cancer.  Thank you to all patients and caregivers touched by Merkel Cell Carcinoma, who shared their experience with this treatment.

The results of this survey were submitted in our patient evidence study to the pan-Canadian Oncology Drug Review (pCODR) on Oct. 24, 2017.

To read the submission, please click here.


For more information about Canadian Cancer Survivor Network, click here.

(image credit click here)

No Comments

Post A Comment

Show Buttons
Hide Buttons

Stay Informed!

Sign up for our e-newsletter to receive updates on Save Your Skin Foundation webinars, events, and projects in the works to help those touched by melanoma, non-melanoma skin cancer, and ocular melanoma.